COVER STORY: Online Extra: Michael J. Fox's Take on Stem Cells
Opposition to this research is "ridiculous," says the actor. It will happen "in other countries now, and we won't have
as much input"
BusinessWeek MAY 24, 2004 Print Edition

During his two-decade career as one of America's most loved actors, Michael J. Fox starred in the TV hits Family Ties
and Spin City, as well as several motion pictures, including The American President, Bright Lights Big City, and the
blockbuster Back to the Future trilogy. Four years ago, he took on a new role, as founder of the nonprofit Michael J.
Fox Foundation for Parkinson's Research. The organization has donated more than $35 million to fund research aimed at
finding a cure for the degenerative brain disease. Fox was diagnosed with Parkinson's in 1991.

On May 8, Fox presented an award to former First Lady Nancy Reagan at a gala fund-raiser for the Juvenile Diabetes
Research Foundation in Beverly Hills, Calif. At the event, Reagan reiterated her opposition to federal restrictions
that limit research on embryonic stem cells -- the highly versatile, but controversial, cells that many scientists
believe may someday be used to cure diseases such as Parkinson's and Alzheimer's. Prior to presenting Reagan with her
award, Fox sat down with BusinessWeek Los Angeles Correspondent Arlene Weintraub to discuss the potential -- and the
politics -- of embryonic stem cells. Edited excerpts from their conversation follow:

Q: How promising do you feel embryonic stem cells might be in the fight to find a cure for Parkinson's disease?
A: Tremendously promising. We know these cells can produce neurons that make dopamine [which is deficient in patients
with the disease]. We also know that dealing with the brain is tricky. You've got to get in there without causing any
damage and then figure out how to get the cells to thrive there.

It presents a lot of problems. Yet embryonic stem cells are so promising that it's hard to understand the hesitation
people have with studying them.

Q: The religious right continues to speak out against experimental cloning techniques that might be used to harvest
stem cells. They fear the same technology could be abused, perhaps in an attempt to clone babies. The U.S. House of
Representatives even passed a bill that proposed criminalizing such research. As a patient, how do you respond when you
hear news like this?
A: It's ridiculous. It's so self-defeating for those of us with Parkinson's and other degenerative diseases. We don't
want to create Frankenstein or clone our Uncle Charlie so we can play poker with him again. It's nuts. We just want to
save lives.

If the government were to allow funding for embryonic stem-cell research, it could use its own power of oversight to
apply standards to the research that people will feel comfortable with. The research will happen anyway. But it will
happen in other countries now, and we won't have as much input.

Q: How might Nancy Reagan speaking out in favor of stem-cell research now influence the debate?
A: It's hugely important. She's viewed as a conservative, but her support of stem cell research will help people to
look beyond politics. She has a lot on her plate -- she could have just sat this out. She'll help drive home the point
that this is not an "issue." It's a potential breakthrough that could have a huge impact on people's lives.

Q: What do you sense the current attitude in Washington is vis-à-vis stem-cell research?
A: It's hard to get them to focus, with everything that's going on in the world right now. But I do think it's trending
positively. This is all about patients and their families. All those people in Washington can trace this issue back to
someone in their family who has an illness that might be affected by this research.

I believe it was a 19th-century scientist who said there are three stages of every breakthrough: First, everyone thinks
you're crazy. Then the church comes out against you. Then it changes the world. We're in stage two. But I don't see any
backsliding in momentum.

Q: Do you believe enough private funding is out there to push stem-cell research forward?
A: No. The science is way ahead of the money. We sit and look back at 2001, when the President banned all funding for
research on everything but a few cell lines, and we think, that's three years -- gone.

Our foundation is trying to fill that void. But it's like the old cliché, the government can throw more money at
something by accident than we could on purpose.

Q: Are other types of research also of interest to you and your foundation?
A: Yes. We would love to find a genetic marker for Parkinson's disease. By the time Parkinson's is diagnosed in most
patients, 80% of dopamine-producing cells are dead. If we could find a marker that would identify the disease when only
5% of those cells are lost, then doctors could get in and start treating it, and that would almost be as good as a
cure.

It might also be possible to put different types of cells into the brain to replace what's dying. We have to be open-
minded and broaden our approach beyond stem cells.

Q: Overall, how confident are you that science is close to finding cures for Parkinson's and other degenerative
diseases?
A: It's easy to look at the research and see that these problems will be solved, though it may take some years. Some
people like to sit back smugly and ask me, "How do you know that embryonic stem cells will work?" I don't know. That's
why we call it "science." It's going to be a journey of 1,000 miles. The steps we're taking now are baby steps. But
we'll go nowhere without them.

Related Content:

Cover Image: Biotech Frontier
http://www.businessweek.com/magazine/content/04_21/b3884002_mz001.htm

Graphic: Mending A Broken Heart
http://www.businessweek.com/magazine/content/04_21/b3884003_mz001.htm

Graphic: Heal Thyself
http://www.businessweek.com/magazine/content/04_21/b3884005_mz001.htm

Graphic: Funding The Future
http://www.businessweek.com/magazine/content/04_21/b3884007_mz001.htm

The Geniuses Of Regeneration
http://www.businessweek.com/magazine/content/04_21/b3884008_mz001.htm

Graphic: Newt Knowhow
http://www.businessweek.com/magazine/content/04_21/b3884009_mz001.htm

Online Extra: Regenerative Medicine's Slow Start
http://www.businessweek.com/magazine/content/04_21/b3884011_mz001.htm

Online Extra: Want To Bank Your Own Stem Cells?
http://www.businessweek.com/magazine/content/04_21/b3884012_mz001.htm

SOURCE: BusinessWeek OnLine North America Edition
http://www.businessweek.com/magazine/content/04_21/b3884010_mz001.htm

* * *

----------------------------------------------------------------------
To sign-off Parkinsn send a message to: mailto:[log in to unmask]
In the body of the message put: signoff parkinsn